[go: up one dir, main page]

MX2008002012A - Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia. - Google Patents

Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.

Info

Publication number
MX2008002012A
MX2008002012A MX2008002012A MX2008002012A MX2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A
Authority
MX
Mexico
Prior art keywords
oil
water
type emulsion
dermatology
topical application
Prior art date
Application number
MX2008002012A
Other languages
English (en)
Inventor
Sandrine Segura-Orsoni
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2008002012A publication Critical patent/MX2008002012A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a una nueva composicion topica bajo la forma de emulsion de tipo aceite en agua, de alta proporcion de fase aceitosa en fase interna, que tiene las propiedades oclusivas y emolientes de un unguento sin presentar los inconvenientes de sensacion grasosa, favoreciendo las propiedades terapeuticas del agente biologicamente activo presente en la composicion.
MX2008002012A 2005-08-11 2006-08-09 Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia. MX2008002012A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0508524A FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie
PCT/FR2006/001930 WO2007020349A1 (fr) 2005-08-11 2006-08-09 Émulsion de type huile-dans-eau pour application topique en dermatologie

Publications (1)

Publication Number Publication Date
MX2008002012A true MX2008002012A (es) 2008-03-25

Family

ID=36273334

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002012A MX2008002012A (es) 2005-08-11 2006-08-09 Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.

Country Status (12)

Country Link
US (1) US20080207570A1 (es)
EP (1) EP1915133A1 (es)
JP (1) JP2009504619A (es)
KR (1) KR20080033389A (es)
CN (1) CN101304729A (es)
AU (1) AU2006281346B2 (es)
BR (1) BRPI0616520A2 (es)
CA (1) CA2617963A1 (es)
FR (1) FR2889662B1 (es)
MX (1) MX2008002012A (es)
RU (2) RU2008108973A (es)
WO (1) WO2007020349A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
EP3838903B1 (en) 2005-12-13 2023-11-22 Incyte Holdings Corporation Pyrrolo[2,3-d]pyrimidine derivative as janus kinase inhibitor
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
CN101932582B (zh) 2007-06-13 2013-09-25 因塞特公司 詹纳斯激酶抑制剂(R)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈的盐
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
WO2010115164A1 (en) * 2009-04-03 2010-10-07 Medicis Pharmaceutical Corporation Topical compositions
US8716303B2 (en) 2009-05-22 2014-05-06 Incyte Corporation N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
RS59632B1 (sr) 2009-05-22 2020-01-31 Incyte Holdings Corp 3-[4-(7h-pirolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]oktan- ili heptan-nitril kao jak inhibitori
DK2473161T3 (en) 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
US20110212035A1 (en) * 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
ME02386B (me) 2010-03-10 2016-09-20 Incyte Holdings Corp Derivati piperidin-4-il azetidina kao inhibitori jak1
NZ603686A (en) 2010-05-21 2014-11-28 Incyte Corp Topical formulation for a jak inhibitor
TW201249845A (en) 2010-11-19 2012-12-16 Incyte Corp Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
PT2686017T (pt) 2011-03-14 2019-10-24 Drug Delivery Solutions Ltd Uma composição oftálmica.
KR20140040819A (ko) 2011-06-20 2014-04-03 인사이트 코포레이션 Ｊａｋ 저해제로서의 아제티디닐 페닐, 피리딜 또는 피라지닐 카르복스아미드 유도체
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
JP5909941B2 (ja) * 2011-09-08 2016-04-27 大正製薬株式会社 ステロイド性抗炎症薬含有外用剤
TW201406761A (zh) 2012-05-18 2014-02-16 Incyte Corp 做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
US10166191B2 (en) 2012-11-15 2019-01-01 Incyte Corporation Sustained-release dosage forms of ruxolitinib
DK2964650T3 (en) 2013-03-06 2019-02-11 Incyte Holdings Corp PROCEDURES AND INTERMEDIATES FOR THE MANUFACTURE OF A JAK INHIBITOR
MX2015013727A (es) * 2013-04-04 2016-02-29 Hyundai Pharm Co Ltd Composicion para preparacion de uso externo con permeabilidad transdermica mejorada.
EP3003272A1 (en) * 2013-06-03 2016-04-13 Tolmar, Inc. Corticosteroid compositions
SI3030227T1 (sl) 2013-08-07 2020-08-31 Incyte Corporation Dozirne oblike s podaljšanim sproščanjem za inhibitor JAK1
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
DE102014010875A1 (de) * 2014-07-25 2016-01-28 Basf Se Transparente Textilpflegemittel
US20180235882A1 (en) 2015-09-02 2018-08-23 Cadila Healthcare Limited Topical compositions comprising corticosteroids
CN108348456B (zh) 2015-10-30 2021-09-17 亭铂医药有限责任公司 异维甲酸制剂及其用途和方法
IL271474B (en) * 2017-06-23 2022-09-01 Salvat Lab Sa Oil-in-water nanoemulsion composition of Clobetasol
US10596161B2 (en) 2017-12-08 2020-03-24 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
LT3746429T (lt) 2018-01-30 2022-05-10 Incyte Corporation (1-(3-fluor-2-(trifluormetil)izonikotinil)piperidin-4-ono) gamybos būdai
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
MY206999A (en) 2018-03-30 2025-01-23 Incyte Corp Treatment of hidradenitis suppurativa using jak inhibitors
BR112022007671A2 (pt) * 2019-11-01 2022-08-09 Colgate Palmolive Co Composições e métodos de higiene pessoal de baixo ph estáveis para os mesmos
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
CN113925800B (zh) * 2021-11-03 2024-09-13 时垠(上海)生物科技有限公司 提高单硬脂酸甘油酯乳化体系乳化能力的方法
KR102831554B1 (ko) * 2022-10-24 2025-07-09 주식회사 코리아나화장품 피부투과촉진 복합물을 포함하는 액정 겔 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JP3454385B2 (ja) * 1993-10-15 2003-10-06 啓次郎 佐藤 Ｏ／ｗ型皮膚用クリームの製造方法
JP2001504463A (ja) * 1996-11-12 2001-04-03 ファルマシア・アンド・アップジョン・カンパニー ククイノキナッツ油を含有する医薬組成物
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
US6699464B1 (en) * 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
WO2004080430A2 (en) * 2003-03-13 2004-09-23 3M Innovative Properties Company Methods of improving skin quality
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US20030129208A1 (en) * 2002-01-07 2003-07-10 Alberts David S. Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses
AU2003252187A1 (en) * 2002-05-15 2003-12-02 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
AR051197A1 (es) * 2004-08-31 2006-12-27 Connetics Australia Pty Ltd Un procedimiento para obtener una microemulsion y sub-micron emulsion y composiciones

Also Published As

Publication number Publication date
AU2006281346B2 (en) 2012-03-29
US20080207570A1 (en) 2008-08-28
FR2889662A1 (fr) 2007-02-16
AU2006281346A1 (en) 2007-02-22
RU2011125550A (ru) 2012-12-27
BRPI0616520A2 (pt) 2011-06-21
JP2009504619A (ja) 2009-02-05
FR2889662B1 (fr) 2011-01-14
CA2617963A1 (fr) 2007-02-22
EP1915133A1 (fr) 2008-04-30
CN101304729A (zh) 2008-11-12
RU2008108973A (ru) 2009-09-20
WO2007020349A1 (fr) 2007-02-22
KR20080033389A (ko) 2008-04-16

Similar Documents

Publication Publication Date Title
MX2008002012A (es) Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.
BRPI0905733B8 (pt) composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
BRPI0508561A (pt) 3-'4-heterociclil-1,2,3-triazol-1-il-n-aril-benzamidas como inibidores da produção de citocinas para o tratamento de doenças inflamatórias crÈnicas
GB2394662A (en) Topical composition for treating pain
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
TW200700059A (en) A topical composition and its uses
LU92484I2 (fr) Paclitaxel formulé comme albumine liée à des nanoparticules
EA201171079A1 (ru) Пенообразующая композиция для местного применения
IL187328A (en) N- Methyl-2-Fluoro- {4- [3- (4-Cyano-3-Trifluoromethylphenyl) -5,5-Dimethyl-4-Oxo-2-Theoxo-Imidazolidin-1-Ill]} Benzamide, Pharmaceuticals Containing It and its use for drug preparation
UA111588C2 (uk) Композиція інгібітора jak для місцевого застосування
PT1485080E (pt) Utilização de adapaleno para o tratamento de desordens dermatológicas
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
WO2007046102A3 (en) Methods for the treatment of hyperhidrosis
CR10305A (es) "derivados sustituidos de cromanol y su uso.
WO2008061724A3 (en) Compositions comprising carnosic acid 12-methylether
WO2007109230A3 (en) Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
BRPI0911469A8 (pt) Inibidores de gm-csf e il-17 para terapia
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
BRPI0715361B8 (pt) uso de polietileno glicol em inflamação relacionada com doenças ou distúrbios tópicos e cicatrização de ferimento
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
TW200745122A (en) New compounds I
MX2007002525A (es) Compuestos de difeniletileno y usos de los mismos.
WO2008070602A3 (en) Topical pharmaceutical composition

Legal Events

Date Code Title Description
FG Grant or registration